Mint Tower Capital Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Mint Tower Capital Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-19,082	Closed	-$346K	–	420
2020 Q3	$346K	Buy	+19,082	New	+$271K	0.04%	171

Mint Tower Capital Management's AKCA Position: Q4 2020 in Review

Mint Tower Capital Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 19,082 shares — an estimated $346K sold.

Mint Tower Capital Management first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $346K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Mint Tower Capital Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Mint Tower Capital Management sold 19,082 Akcea Therapeutics Inc shares in Q4 2020, an estimated $346K.
Mint Tower Capital Management first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Mint Tower Capital Management's Akcea Therapeutics Inc position peaked at $346K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Mint Tower Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.